SavedAdd your journal

Journals / Acta Medica / 2018 / Cilt: 49 - Sayı: 2

Potential Impacts of Gut Microbiota on Immune System Related Diseases: Current Studies and Future Challenges

Tayfun Hilmi AKBABA
Banu BALCI PEYNİRCİOĞLU
Pages
31–37
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These features make microbiota a potential therapeutic tool or biomarker for a spate of disease in clinic applications.This review summarizes hostgut microbiota interaction, role of microbiota in immune-related diseases, and potential therapeutic approaches.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Human microbiota includes trillions of cohabitant microorganisms in a symbiotic relationship.
📊
Key Findings & Data:Human microbiome profiling studies has accelerated microbiota studies and interest to microbiota and disease relationship .
💡
Conclusion & Impact:These features make microbiota a potential therapeutic tool or biomarker for a spate of disease in clinic applications.This review summarizes hostgut microbiota interaction, role of microbiota in immune-related diseases, and potential therapeutic approaches.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Human microbiota includes trillions of cohabitant microorganisms in a symbiotic relationship. They directly or indirectly communicate with immune system. Human microbiome profiling studies has accelerated microbiota studies and interest to microbiota and disease relationship . Some metabolic activities of human microbiota were known, but in recent years many different roles in addition to metabolic activities, have been shown. It can affect systems and mechanisms, and most importantly clinical course of diseases in dysbiosis condition, and reduces most symptoms when symbiosis is provided. These features make microbiota a potential therapeutic tool or biomarker for a spate of disease in clinic applications.This review summarizes hostgut microbiota interaction, role of microbiota in immune-related diseases, and potential therapeutic approaches.

🔖

Cite This Article

AKBABA, T. H., PEYNİRCİOĞLU, B. B. (2018). Potential Impacts of Gut Microbiota on Immune System Related Diseases: Current Studies and Future Challenges. Acta Medica, Cilt: 49 - Sayı: 2, 31–37. https://ajindex.com/articles/144218

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Turnbaugh PJ, Ley RE, Hamady M,, et al. The human microbiome project. Nature 2007; 449: 804-810.
  2. Shreiner AB, Kao JY, Young VB. The gut microbiome in health and in disease. Curr Opin Gastroenterol 2015; 31: 69-75.
  3. Group NHW, Peterson J, Garges S, et al. The NIH Human Microbiome Project. Genome Res 2009; 19: 2317-2323. Sirisinha S. The potential impact of gut microbiota on your health:Current status and future challenges. Asian Pac J Allergy Immunol 2016; 34: 249-264.
  4. Conlan S, Kong HH, Segre JA. Species-level analysis of DNA sequence data from the NIH Human Microbiome Project. PLoS One 2012; 7: e47075. Human Microbiome Project C. A framework for human microbiome research. Nature 2012; 486: 215-221.
  5. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464: 59-65.
  6. Guaraldi F, Salvatori G. Effect of breast and formula feed- ing on gut microbiota shaping in newborns. Front Cell Infect Microbiol 2012; 2: 94. Flint HJ, Scott KP, Duncan SH, et al. Microbial degradation of complex carbohydrates in the gut. Gut Microbes 2012; 3: 289-306.
  7. Duncan SH, Flint HJ. Probiotics and prebiotics and health in ageing populations. Maturitas 2013; 75: 44-50.
  8. Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature 2011; 473: 174-180. Hebuterne X. Gut changes attributed to ageing: effects on intestinal microflora. Curr Opin Clin Nutr Metab Care 2003; 6: 49-54.
  9. Patel PJ, Singh SK, Panaich S, et al. The aging gut and the role of prebiotics, probiotics, and synbiotics: A review. Journal of Clinical Gerontology and Geriatrics 2014; 5: 3-6.
  10. Larsbrink J, Rogers TE, Hemsworth GR, et al. A discrete genetic locus confers xyloglucan metabolism in select human gut Bacteroidetes. Nature 2014; 506: 498-502.
  11. Kim D, Yoo SA, Kim WU. Gut microbiota in autoimmuni- ty: potential for clinical applications. Arch Pharm Res 2016; 39: 1565-1576. den Besten G, van Eunen K, Groen AK, et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 2013; 54: 2325-2340.
  12. Jandhyala SM, Talukdar R, Subramanyam C, et al. Role of the normal gut microbiota. World J Gastroenterol 2015; 21: 8787-8803.
  13. Johansson ME, Phillipson M, Petersson J, et al. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A 2008; 105: 15064-15069.
  14. Kim YS, Ho SB. Intestinal goblet cells and mucins in health and disease: rece